危重患儿凝血功能障碍标准:PODIUM共识会议
本共识基于1992年至2020年的系统综述,提出在无肝功能障碍的危重患儿中,符合血小板计数<100 000 cells per μL、INR>1.5、纤维蛋白原<150 mg/dL、D-二聚体>10倍正常上限(或超过检测上限且该上限<10倍正常上限)中至少2项,可反映凝血功能障碍。该标准需未来验证。
要点
- 无肝功能障碍的危重患儿,符合4项凝血指标中至少2项提示凝血功能障碍。
- 4项指标为血小板<100 000 cells per μL、INR>1.5、纤维蛋白原<150 mg/dL、D-二聚体>10倍正常上限。
- 该标准基于系统综述证据提出,尚需未来验证。
核心结论
- 系统综述支持在无肝功能障碍的危重患儿中,符合至少2项凝血指标可反映凝血功能障碍。
研究设计与样本
- 系统检索PubMed和Embase从1992年1月至2020年1月的文献,纳入评估危重患儿凝血功能障碍与不良结局的研究。
主要发现
- 系统综述支持至少2项以下标准反映无肝功能障碍的危重患儿凝血功能障碍:血小板计数<100 000 cells per μL、INR>1.5、纤维蛋白原<150 mg/dL、D-二聚体>10倍正常上限或超过检测上限且该上限<10倍正常上限。
关键数值与推荐
- 血小板计数<100 000 cells per μL。
- INR>1.5。
- 纤维蛋白原<150 mg/dL。
- D-二聚体>10倍正常上限,或超过检测上限且该上限<10倍正常上限。
- 无肝功能障碍情况下符合至少2项上述标准。
临床怎么用
- 临床可参考上述4项凝血指标及阈值,在无肝功能障碍的危重患儿中识别凝血功能障碍。
局限性
- 所提出的凝血功能障碍标准受现有证据限制,需未来验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Previous criteria for coagulation dysfunction in critically ill children were based mainly on expert opinion. OBJECTIVE: To evaluate current evidence regarding coagulation tests associated with adverse outcomes in children to inform criteria for coagulation dysfunction during critical illness. DATA SOURCES: Electronic searches of PubMed and Embase were conducted from January 1992 to January 2020 by using a combination of medical subject heading terms and text words to define concepts of coagulation dysfunction, pediatric critical illness, and outcomes of interest. STUDY SELECTION: Studies were included if critically ill children with coagulation dysfunction were evaluated, if performance characteristics of assessment and/or scoring tools to screen for coagulation dysfunction were evaluated, and if outcomes related to mortality or functional status, organ-specific outcomes, or other patient-centered outcomes were assessed. DATA EXTRACTION: Data were abstracted from each eligible study into a standard data extraction form, along with risk of bias assessment, by a task force member. RESULTS: The systematic review supports the presence of at least 2 of the following criteria reflecting coagulation dysfunction in the absence of liver dysfunction: platelet count <100 000 cells per μL, international normalized ratio >1.5, fibrinogen level <150 mg/dL, and D-dimer value above 10 times the upper limit of normal, or above the assay's upper limit of detection if this limit is below 10 times the upper limit of normal. LIMITATIONS: The proposed criteria for coagulation dysfunction are limited by the available evidence and will require future validation. CONCLUSIONS: Validation of the proposed criteria and identified scientific priorities will enhance our understanding of coagulation dysfunction in critically ill children.
引用
- Faustino EVS, Karam O, Parker RI, et al. Coagulation Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference. Pediatrics. 2022. PMID: 34970670. doi:10.1542/peds.2021-052888L
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。